⏳ Fetching live dividend data...
Home › Calculator › IPA Dividend Calculator 2026
ImmunoPrecise Antibodies Ltd. · NASDAQ
Price: $1.62 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in IPA → $1904455.86M in 10 years · $154,514,273,900.43/month
ImmunoPrecise Antibodies Ltd. (IPA) is a global biotechnology firm that, through its subsidiaries, focuses on the development and production of antibodies, alongside offering a broad spectrum of related scientific services. Its operational footprint spans across the United States, Canada, Europe, Australia, and other international territories. For the research community, IPA delivers a diverse portfolio of products, including various types of antibodies, enzymes, enzyme activity assays, specialized animal products for arthritis studies, proteins (such as deiminated proteins), organoid growth factors, and hybridoma reagents. As a comprehensive Contract Research Organization (CRO), IPA provides an extensive suite of services covering the entire antibody discovery and development pipeline. This includes customized antigen design, modeling, and manufacturing; advanced B cell analysis encompassing sorting, screening, and sequencing; the development and screening of custom, immune, and naive phage display libraries; multi-species antibody discovery, including from transgenic animals; and the creation of specialized antibody formats such as bi-specific, tri-specific, VHH, and VNAR (shark) antibodies. Further expertise lies in DNA cloning, protein and antibody downstream processing, label-free biosensor-based antibody characterization, and antibody engineering. They also provide transient and stable cell line generation, antibody optimization and humanization, high-throughput hybridoma production with multiplexed screening and clone selection, and cryopreservation services. The company actively engages in strategic research collaborations, notably partnering with Pierre Fabre S.A. for antibody discovery initiatives. Additionally, it collaborates with Elektrofi, Inc. to investigate a high-concentration formulation for its COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was established in 1983 and maintains its headquarters in Victoria, Canada.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IPA position with:
Real after-tax yield depends on where you live and how you hold IPA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 123.46% | 120.66% | $12,346 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 104.94% | 102.14% | $10,494 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 98.77% | 95.97% | $9,877 / yr |
| 🇬🇧 UK ISA | 0% | 123.46% | 120.66% | $12,346 / yr |
| 🇬🇧 UK Taxable | 8.75% | 112.66% | 109.86% | $11,266 / yr |
| 🇨🇦 TFSA | 0% | 123.46% | 120.66% | $12,346 / yr |
| 🇨🇦 CA Taxable | 25% | 92.59% | 89.80% | $9,260 / yr |
| 🇦🇺 Super (pension) | 15% | 104.94% | 102.14% | $10,494 / yr |
| 🇦🇺 AU Taxable | 30% | 86.42% | 83.62% | $8,642 / yr |
| 🇩🇪 DE Taxable | 26.375% | 90.90% | 88.10% | $9,090 / yr |
| 🇫🇷 FR Taxable | 30% | 86.42% | 83.62% | $8,642 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
IPA pays quarterly — 4 times per year. Next ex-div: TBD.
How IPA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IPA sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IPA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
ImmunoPrecise Antibodies Ltd. (IPA) is currently trading at $1.62, 90% below its 52-week high. The current dividend yield is 123.46% based on an annual payout of $2.00 per share.
ImmunoPrecise Antibodies Ltd. (IPA) is a healthcare stock currently trading at $1.62 with a dividend yield of 123.46%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever